The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Aadi Bioscience Inc | Common | 00032Q104 | 6,456,277 | 509,572 | SH | SOLE | 509,572 | 0 | 0 | |||
Alpine Immune Sciences Inc | Common | 02083G100 | 9,405,306 | 914,913 | SH | SOLE | 914,913 | 0 | 0 | |||
Aclaris Therapeutics, Inc. | Common | 00461U105 | 9,318,803 | 898,631 | SH | SOLE | 898,631 | 0 | 0 | |||
Aligos Therapeutics Inc | Common | 01626L105 | 3,444,166 | 3,547,030 | SH | SOLE | 3,547,030 | 0 | 0 | |||
Allakos Inc | Common | 01671P100 | 13,027,680 | 2,988,000 | SH | SOLE | 2,988,000 | 0 | 0 | |||
ALX Oncology Holdings Inc | Common | 00166B105 | 31,692,560 | 4,220,048 | SH | SOLE | 4,220,048 | 0 | 0 | |||
Amyris, Inc | Common | 03236M200 | 7,983,353 | 7,750,828 | SH | SOLE | 7,750,828 | 0 | 0 | |||
Arcellx Inc. | Common | 03940C100 | 13,716,282 | 433,785 | SH | SOLE | 433,785 | 0 | 0 | |||
Arrowhead Pharmaceuticals Inc | Common | 04280A100 | 4,900,076 | 137,411 | SH | SOLE | 137,411 | 0 | 0 | |||
Aslan Pharmaceuticals Ltd | ADS | 04522R101 | 10,369,314 | 2,840,908 | SH | SOLE | 2,840,908 | 0 | 0 | |||
Astria Therapeutics Inc | Common | 04635X102 | 14,004,388 | 1,681,199 | SH | SOLE | 1,681,199 | 0 | 0 | |||
Avadel Pharmaceuticals PLC | ADR | 05337M104 | 63,111,429 | 3,829,577 | SH | SOLE | 3,829,577 | 0 | 0 | |||
BioAtla Inc | Common | 09077B104 | 1,911,543 | 637,181 | SH | SOLE | 637,181 | 0 | 0 | |||
Bolt Therapeutics Inc | Common | 097702104 | 4,955,252 | 3,871,291 | SH | SOLE | 3,871,291 | 0 | 0 | |||
Chinook Therapeutics Inc | Common | 16961L106 | 35,918,051 | 934,879 | SH | SOLE | 934,879 | 0 | 0 | |||
Clene Inc | Common | 185634102 | 3,706,910 | 4,520,622 | SH | SOLE | 4,520,622 | 0 | 0 | |||
Codexis, Inc | Common | 192005106 | 1,086,803 | 388,144 | SH | SOLE | 388,144 | 0 | 0 | |||
Cogent Biosciences Inc | Common | 19240Q201 | 26,580,101 | 2,244,941 | SH | SOLE | 2,244,941 | 0 | 0 | |||
Compass Therapeutics Inc | Common | 20454B104 | 11,308,153 | 3,556,023 | SH | SOLE | 3,556,023 | 0 | 0 | |||
DBV Technologies SA | Sponsored ADR | 23306J101 | 5,146,863 | 2,708,875 | SH | SOLE | 2,708,875 | 0 | 0 | |||
Delcath Systems, Inc. | Common | 24661P807 | 6,872,328 | 1,178,787 | SH | SOLE | 1,178,787 | 0 | 0 | |||
Dyne Therapeutics Inc | Common | 26818M108 | 6,498,473 | 577,642 | SH | SOLE | 577,642 | 0 | 0 | |||
Fulcrum Therapeutics Inc | Common | 359616109 | 1,815,000 | 550,000 | SH | SOLE | 550,000 | 0 | 0 | |||
Genetron Holdings Ltd | ADS | 37186H100 | 7,556,294 | 8,124,174 | SH | SOLE | 8,124,174 | 0 | 0 | |||
Geron Corp | Common | 374163103 | 53,044,075 | 16,524,634 | SH | SOLE | 16,524,634 | 0 | 0 | |||
Gracell Biotechnologies Inc | SPONSORED ADS | 38406L103 | 15,123,517 | 3,969,427 | SH | SOLE | 3,969,427 | 0 | 0 | |||
Harmony Biosciences Holdings Inc | Common | 413197104 | 91,713,832 | 2,606,247 | SH | SOLE | 2,606,247 | 0 | 0 | |||
Homology Medicines, Inc. | Common | 438083107 | 327,510 | 370,068 | SH | SOLE | 370,068 | 0 | 0 | |||
Icosavax, Inc. | Common | 45114M109 | 16,926,360 | 1,704,568 | SH | SOLE | 1,704,568 | 0 | 0 | |||
Immunic Inc | Common | 4525EP101 | 1,586,782 | 632,184 | SH | SOLE | 632,184 | 0 | 0 | |||
Impel NeuroPharma Inc | Common | 45258K109 | 3,663,682 | 2,884,789 | SH | SOLE | 2,884,789 | 0 | 0 | |||
Instil Bio Inc | Common | 45783C101 | 6,880,220 | 12,486,787 | SH | SOLE | 12,486,787 | 0 | 0 | |||
IO Biotech Inc | Common | 449778109 | 5,895,390 | 3,015,545 | SH | SOLE | 3,015,545 | 0 | 0 | |||
Iovance Biotherapeutics Inc | Common | 462260100 | 4,611,601 | 655,057 | SH | SOLE | 655,057 | 0 | 0 | |||
KalVista Pharmaceuticals Inc. | Common | 483497103 | 7,704,072 | 856,008 | SH | SOLE | 856,008 | 0 | 0 | |||
Olema Pharmaceuticals Inc | Common | 68062P106 | 12,093,617 | 1,339,271 | SH | SOLE | 1,339,271 | 0 | 0 | |||
Precision Biosciences Inc | Common | 74019P108 | 73,774 | 140,255 | SH | SOLE | 140,255 | 0 | 0 | |||
Rezolute Inc | Common | 76200L309 | 969,157 | 489,473 | SH | SOLE | 489,473 | 0 | 0 | |||
Sera Prognostics Inc | Common | 81749D107 | 6,115,556 | 1,856,011 | SH | SOLE | 1,856,011 | 0 | 0 | |||
Sinovac Biotech Ltd. | SHS | P8696W104 | 615,369,410 | 5,900,000 | SH | SOLE | 5,900,000 | 0 | 0 | |||
Tarsus Pharmaceuticals Inc | Common | 87650L103 | 40,877,954 | 2,262,200 | SH | SOLE | 2,262,200 | 0 | 0 | |||
Terns Pharmaceuticals Inc | Common | 880881107 | 58,257,430 | 6,657,992 | SH | SOLE | 6,657,992 | 0 | 0 | |||
VectivBio Holding AG | Common | H9060V101 | 39,362,771 | 2,333,300 | SH | SOLE | 2,333,300 | 0 | 0 | |||
Ventyx Biosciences Inc | Common | 92332V107 | 13,844,060 | 422,075 | SH | SOLE | 422,075 | 0 | 0 | |||
Verastem Inc | Common | 92337C203 | 11,446,150 | 1,538,461 | SH | SOLE | 1,538,461 | 0 | 0 | |||
Verona Pharma PLC | ADS | 925050106 | 89,843,267 | 4,249,918 | SH | SOLE | 4,249,918 | 0 | 0 | |||
Viridian Therapeutics Inc | Common | 92790C104 | 39,924,545 | 1,678,207 | SH | SOLE | 1,678,207 | 0 | 0 | |||
Zai Lab Ltd ADR | ADR | 98887Q104 | 12,353,854 | 445,505 | SH | SOLE | 445,505 | 0 | 0 |